SEP 9, 2026 · JOURNAL ARTICLE
ctDNA and immune biomarker testing for molecular residual disease surveillance and immune stratification in cancer
Frontiers in Medicine
A conceptual review proposing an integrative framework for ctDNA and immune biomarkers in MRD surveillance, without new primary data or prospective validation of the proposed model.